| Peer-Reviewed

Central Giant Cell Granuloma of the Mandible: A Case Report

Received: 7 July 2020    Accepted: 3 August 2020    Published: 13 August 2020
Views:       Downloads:
Abstract

The central giant cell granuloma (CGCG) of the jaws is a rare benign tumour of the mandible (lower jaw) and the maxilla (upper jaw) characterized by destruction of the bone, loss of symmetry of the face and displacement of teeth and tooth germs, especially in younger patients. It is asymptomatic and present with slow growth often accompanied by dental mobility. The removal of this tumour is mutilating and is followed prosthetic rehabilitation. The aim of this study was to report a case of central giant cell granuloma localizated to the symphyseal region in a young patient. The case reported is that of a 14-year-old girl who received a consultation for a tumor in the symphysical region causing an aesthetic impact. The tumor was firm, painless and had been developing for about a year. The cortical were broken in places, in transverse, sagittal and coronal sections. The treatment consisted of her excision under general anesthesia causing a significant loss of substance. The tumor mass, very hemorrhagic, was extended to the buccal floor. At the end of the intervention, a significant loss of substance was observed. Two months later, a partial adjunct prosthesis was performed. The anatomo-pathological examination showed of several multinucleated giant cells, a few histiocytes, lymphocytes and fibroblasts. The removal of this aggressive tumour remains mutilating, with significant psychological repercussions. More recently, antiangiogenic therapy with interferon alpha has been successfully applied.

Published in International Journal of Clinical Oral and Maxillofacial Surgery (Volume 6, Issue 2)
DOI 10.11648/j.ijcoms.20200602.14
Page(s) 40-43
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Central Giant Cell Granuloma, Mandible, Removal

References
[1] Barnes L. WHO Odontogenic Tumours. IARC Press; 2005, 285-330.
[2] Chuong R, Kaban LB, Kozakewich H, Perez-Atayde A. Central giant cell lesions of the jaws: a clinicopathologic study. J Oral Maxillofac Surg 1986; 44: 708-713.
[3] Chrcanovic BR, Gomes CC, Gomez RS. Central giant cell lesion of the jaws: an updated analysis of 2270 cases reported in the literature. J Oral Pathol Med 2018; 47: 731-739.
[4] Whitaker SB, Waldron CA. Central giant cell lesions of the jaws. A clinical, radiologic, and histopathologic study. Oral Surg Oral Med Oral Pathol 1993; 75: 199-208.
[5] Stavropoulos F, Katz J. Central giant cell granulomas: a systematic review of the radiographic characteristics with the addition of 20 new cases. Dentomaxillofac Radiol. 2003; 31: 213-217.
[6] Abdelqader S, Roche N, Manfredi L, Papon JF, Maman L, Ferré F. Up-to date review and case report giant-cell granuloma: 2 cases reports. J Oral Med Oral Surg 2018; 24: 182-186.
[7] Bonolis A, Euvrard E, Meyer C, Louvrier A. Central giant-cell granuloma located in the mandibular symphyseal region of a child. J Oral Med Oral Surg 2018; 24: 53-56.
[8] Ahossi V, Vincent S, Duvillard C, Larras P, Petrella T, Perrin D. Giant cell reparative granuloma of the maxilla: a case report. Rev Odontostomatol 2010; 39: 135-144.
[9] Pham Dang N, Longeac M, Picard M, Devoize L, Barthélémy I. Central giant cell granuloma in children: presentation of different therapeutic options. Rev Stomatol Chir Maxillofac Chir Orale 2016; 117: 142-146.
[10] Abdo EN, Alves LC, Rodrigues AS, Mesquita RA, Gomes RS. Treatment of a central giant cell granuloma with intralesional corticosteroids. Brit J Oral Maxilfac Surg 2005; 43: 74-76.
[11] Kurtz M, Mesa M, Alberto P. Treatment of central giant cell lesion of the mandible with intralesional glucocorticosteroids. Oral Surg Oral Med Oral Path Oral Rad Endo 2001; 91: 636-637.
[12] Saim Y, Mutan HA. Management of central giant cell granuloma of mandible using intralesional corticosteroids: case report and review of literature. J Oral Maxillofac Surg 2013; 71: 721-722.
[13] De Lange J, van den Akker HP, Engelshove HA, van den Berg H, Klip H. Calcitonin therapy in central giant cell granuloma of the jaw: a randomized double-blind placebo-controlled study. Int J Oral Maxillofac Surg 2006; 35: 791-795.
[14] Barthélémy I, Mondié JM. Giant cell tumors and pseudogiant cell tumors of the jaws. Rev Stomatol Chir Maxillofac 2009; 110: 209-213.
[15] Suárez-Roa MDL, Reveiz L, Ruíz-Godoy RLM, Asbun-Bojalil J, Meneses-García A. Interventions for central giant cell granuloma (CGCG) of the jaws. The Cochrane Library 2009, Issue 4, 16p.
[16] Kudva A, Cariappa KM, Dhara V, Solomon M. Central giant cell granuloma: An uncommon presentation. Oral and Maxillofacial Surgery Cases 4, 2018; 135-140.
[17] Saghravaniana N, Mohtashama N, Vahedib M, Ghazia N, Aghaee MA. Immunohistochemical evaluation of VEGF and tryptase forangiogenesis and mast cell counting in giant cell granulomasof the jaws. J Oral and Maxillofac Surg Med and Pathol 2018; 30 (4): 365-370.
Cite This Article
  • APA Style

    Babacar Tamba, Mouhammad Kane, Mamadou Diatta, Bintou Catherine Gassama, Alpha Kounta, et al. (2020). Central Giant Cell Granuloma of the Mandible: A Case Report. International Journal of Clinical Oral and Maxillofacial Surgery, 6(2), 40-43. https://doi.org/10.11648/j.ijcoms.20200602.14

    Copy | Download

    ACS Style

    Babacar Tamba; Mouhammad Kane; Mamadou Diatta; Bintou Catherine Gassama; Alpha Kounta, et al. Central Giant Cell Granuloma of the Mandible: A Case Report. Int. J. Clin. Oral Maxillofac. Surg. 2020, 6(2), 40-43. doi: 10.11648/j.ijcoms.20200602.14

    Copy | Download

    AMA Style

    Babacar Tamba, Mouhammad Kane, Mamadou Diatta, Bintou Catherine Gassama, Alpha Kounta, et al. Central Giant Cell Granuloma of the Mandible: A Case Report. Int J Clin Oral Maxillofac Surg. 2020;6(2):40-43. doi: 10.11648/j.ijcoms.20200602.14

    Copy | Download

  • @article{10.11648/j.ijcoms.20200602.14,
      author = {Babacar Tamba and Mouhammad Kane and Mamadou Diatta and Bintou Catherine Gassama and Alpha Kounta and Abdou Ba and Ndeye Fatou Kebe and Soukeye Dia Tine},
      title = {Central Giant Cell Granuloma of the Mandible: A Case Report},
      journal = {International Journal of Clinical Oral and Maxillofacial Surgery},
      volume = {6},
      number = {2},
      pages = {40-43},
      doi = {10.11648/j.ijcoms.20200602.14},
      url = {https://doi.org/10.11648/j.ijcoms.20200602.14},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcoms.20200602.14},
      abstract = {The central giant cell granuloma (CGCG) of the jaws is a rare benign tumour of the mandible (lower jaw) and the maxilla (upper jaw) characterized by destruction of the bone, loss of symmetry of the face and displacement of teeth and tooth germs, especially in younger patients. It is asymptomatic and present with slow growth often accompanied by dental mobility. The removal of this tumour is mutilating and is followed prosthetic rehabilitation. The aim of this study was to report a case of central giant cell granuloma localizated to the symphyseal region in a young patient. The case reported is that of a 14-year-old girl who received a consultation for a tumor in the symphysical region causing an aesthetic impact. The tumor was firm, painless and had been developing for about a year. The cortical were broken in places, in transverse, sagittal and coronal sections. The treatment consisted of her excision under general anesthesia causing a significant loss of substance. The tumor mass, very hemorrhagic, was extended to the buccal floor. At the end of the intervention, a significant loss of substance was observed. Two months later, a partial adjunct prosthesis was performed. The anatomo-pathological examination showed of several multinucleated giant cells, a few histiocytes, lymphocytes and fibroblasts. The removal of this aggressive tumour remains mutilating, with significant psychological repercussions. More recently, antiangiogenic therapy with interferon alpha has been successfully applied.},
     year = {2020}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Central Giant Cell Granuloma of the Mandible: A Case Report
    AU  - Babacar Tamba
    AU  - Mouhammad Kane
    AU  - Mamadou Diatta
    AU  - Bintou Catherine Gassama
    AU  - Alpha Kounta
    AU  - Abdou Ba
    AU  - Ndeye Fatou Kebe
    AU  - Soukeye Dia Tine
    Y1  - 2020/08/13
    PY  - 2020
    N1  - https://doi.org/10.11648/j.ijcoms.20200602.14
    DO  - 10.11648/j.ijcoms.20200602.14
    T2  - International Journal of Clinical Oral and Maxillofacial Surgery
    JF  - International Journal of Clinical Oral and Maxillofacial Surgery
    JO  - International Journal of Clinical Oral and Maxillofacial Surgery
    SP  - 40
    EP  - 43
    PB  - Science Publishing Group
    SN  - 2472-1344
    UR  - https://doi.org/10.11648/j.ijcoms.20200602.14
    AB  - The central giant cell granuloma (CGCG) of the jaws is a rare benign tumour of the mandible (lower jaw) and the maxilla (upper jaw) characterized by destruction of the bone, loss of symmetry of the face and displacement of teeth and tooth germs, especially in younger patients. It is asymptomatic and present with slow growth often accompanied by dental mobility. The removal of this tumour is mutilating and is followed prosthetic rehabilitation. The aim of this study was to report a case of central giant cell granuloma localizated to the symphyseal region in a young patient. The case reported is that of a 14-year-old girl who received a consultation for a tumor in the symphysical region causing an aesthetic impact. The tumor was firm, painless and had been developing for about a year. The cortical were broken in places, in transverse, sagittal and coronal sections. The treatment consisted of her excision under general anesthesia causing a significant loss of substance. The tumor mass, very hemorrhagic, was extended to the buccal floor. At the end of the intervention, a significant loss of substance was observed. Two months later, a partial adjunct prosthesis was performed. The anatomo-pathological examination showed of several multinucleated giant cells, a few histiocytes, lymphocytes and fibroblasts. The removal of this aggressive tumour remains mutilating, with significant psychological repercussions. More recently, antiangiogenic therapy with interferon alpha has been successfully applied.
    VL  - 6
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Department of Oral Surgery, Odontology and Stomatology Institute, Cheikh Anta Diop University, Dakar, Senegal; General Hospital Idrissa Pouye, Dakar, Senegal

  • Department of Oral Surgery, Odontology and Stomatology Institute, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Oral Surgery, Odontology and Stomatology Institute, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Oral Surgery, Odontology and Stomatology Institute, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Oral Surgery, Odontology and Stomatology Institute, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Oral Surgery, Odontology and Stomatology Institute, Cheikh Anta Diop University, Dakar, Senegal

  • General Hospital Idrissa Pouye, Dakar, Senegal

  • Department of Oral Surgery, Odontology and Stomatology Institute, Cheikh Anta Diop University, Dakar, Senegal; General Hospital Idrissa Pouye, Dakar, Senegal

  • Sections